Cupid receives CE (EU IVDR) certification for Pregnancy, Syphilis test kits

20 Oct 2025 Evaluate

Cupid has been granted CE (EU IVDR) Certification for two of its key in-vitro diagnostic (IVD) devices - the CupiSURE Pregnancy (hCG) Test Kit and the CupiKIT Syphilis Antibody Test Kit. These certifications confirm compliance with the European Union Regulation (EU) 2017/746 (IVDR), authorizing Cupid to distribute these kits across the European Economic Area and other CE-recognized global markets. The development marks a major step in Cupid’s transition from an Indian healthcare exporter to a globally certified IVD solutions provider.

Cupid’s certified IVD kits target two of the fastest-growing diagnostic categories: Pregnancy (hCG) Test Kits - Global market valued at $1.7 billion in 2024, projected to reach $2.9 billion by 2034 (CAGR around 5.4%). Syphilis Immunoassay Diagnostics - Estimated at $611 million in 2025, expected to grow to $993 million by 2034 (CAGR around 5.6%).

In addition, Cupid is in the final stages of securing CE (EU IVDR) Certification for its HIV 1 & 2 Antibody and Hepatitis B Antigen IVD kits, expected by December 2025 - products that address some of the world’s largest and most urgent diagnostic markets.

Cupid manufactures and markets varieties of male and female condoms, water-based lubricant, latex dental dams and probe covers. The company has a diverse product basket available in many countries worldwide.


Cupid Share Price

364.60 -9.20 (-2.46%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Hindustan Unilever 2339.00
Godrej Consumer Prod 1135.80
Dabur India 509.80
Colgate Palmol. (I) 2164.75
P&G Hygiene 12583.80
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×